{"id":"https://openalex.org/W34712602","doi":"https://doi.org/10.1161/circ.120.suppl_18.s1095-c","title":"Abstract 5458: VIA-3196, a Liver-directed Thyroid Beta Agonist for Treating Cardiometabolic Disease","display_name":"Abstract 5458: VIA-3196, a Liver-directed Thyroid Beta Agonist for Treating Cardiometabolic Disease","publication_year":2009,"publication_date":"2009-11-03","ids":{"openalex":"https://openalex.org/W34712602","doi":"https://doi.org/10.1161/circ.120.suppl_18.s1095-c","mag":"34712602"},"language":"en","primary_location":{"id":"doi:10.1161/circ.120.suppl_18.s1095-c","doi":"https://doi.org/10.1161/circ.120.suppl_18.s1095-c","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1161/circ.120.suppl_18.s1095-c","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5114115410","display_name":"Rebecca A. Taub","orcid":"https://orcid.org/0000-0003-4509-7005","observed_orcids":["https://orcid.org/0000-0003-4509-7005"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rebecca Taub","raw_affiliation_strings":["VIA Pharmaceuticals, Princeton, NJ","Rebecca Taub"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VIA Pharmaceuticals, Princeton, NJ","institution_ids":[]},{"raw_affiliation_string":"Rebecca Taub","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084966112","display_name":"Joseph S. Grimsby","orcid":"https://orcid.org/0000-0002-0388-1427","observed_orcids":["https://orcid.org/0000-0002-0388-1427"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph Grimsby","raw_affiliation_strings":["Roche, Nutley, NJ","Joseph Grimsby"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche, Nutley, NJ","institution_ids":[]},{"raw_affiliation_string":"Joseph Grimsby","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030776764","display_name":"J. Douglas Larigan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. D Larigan","raw_affiliation_strings":["Roche, Nutley, NJ","J. D Larigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche, Nutley, NJ","institution_ids":[]},{"raw_affiliation_string":"J. D Larigan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067641176","display_name":"Sherrie Pietranico","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sherrie Pietranico","raw_affiliation_strings":["Roche, Nutley, NJ","Sherrie Pietranico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche, Nutley, NJ","institution_ids":[]},{"raw_affiliation_string":"Sherrie Pietranico","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031022192","display_name":"Mark T. Dvorozniak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Dvorozniak","raw_affiliation_strings":["Roche, Nutley, NJ","Mark Dvorozniak"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche, Nutley, NJ","institution_ids":[]},{"raw_affiliation_string":"Mark Dvorozniak","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037285842","display_name":"Karin Conde\u2010Knape","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karin Conde-Knape","raw_affiliation_strings":["Roche, Nutley, NJ","Karin Conde-Knape"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche, Nutley, NJ","institution_ids":[]},{"raw_affiliation_string":"Karin Conde-Knape","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"120","issue":"suppl_18","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments","score":0.9452999830245972,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.010099999606609344,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thyromimetics","display_name":"thyromimetics","score":0.875},{"id":"https://openalex.org/keywords/cardiometabolic-disease","display_name":"cardiometabolic disease","score":0.8840000033378601},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.9470000267028809},{"id":"https://openalex.org/keywords/non-hdl-cholesterol","display_name":"non-HDL cholesterol","score":0.8970000147819519},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.7820000052452087},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.7879999876022339},{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":0.9330000281333923},{"id":"https://openalex.org/keywords/hepatic-steatosis","display_name":"hepatic steatosis","score":0.8230000138282776},{"id":"https://openalex.org/keywords/reverse-cholesterol-transport","display_name":"reverse cholesterol transport","score":0.7319999933242798},{"id":"https://openalex.org/keywords/cyp7a1","display_name":"CYP7A1","score":0.7139999866485596},{"id":"https://openalex.org/keywords/abcb11","display_name":"ABCB11","score":0.9340000152587891},{"id":"https://openalex.org/keywords/thyroid-stimulating-hormone","display_name":"thyroid-stimulating hormone","score":0.38499999046325684}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9627022743225098},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5147466659545898},{"id":"https://openalex.org/C526584372","wikidata":"https://www.wikidata.org/wiki/Q16399","display_name":"Thyroid","level":2,"score":0.49764755368232727},{"id":"https://openalex.org/C2776174256","wikidata":"https://www.wikidata.org/wiki/Q830842","display_name":"BETA (programming language)","level":2,"score":0.4848848283290863},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4752649664878845},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45001286268234253},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3844503164291382},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3232516050338745},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12881425023078918},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1161/circ.120.suppl_18.s1095-c","doi":"https://doi.org/10.1161/circ.120.suppl_18.s1095-c","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1161/circ.120.suppl_18.s1095-c","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.5400000214576721,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2141742236","https://openalex.org/W2012868945","https://openalex.org/W2013820827","https://openalex.org/W4384946576","https://openalex.org/W6990774529","https://openalex.org/W2029473474","https://openalex.org/W2154456365","https://openalex.org/W1984669793","https://openalex.org/W2022022576","https://openalex.org/W4235060481"],"abstract_inverted_index":{"Thyroid":[0],"hormone":[1],"has":[2,301],"beneficial":[3],"metabolic":[4,58],"benefits":[5,59],"such":[6],"as":[7,76,188,190,218],"cholesterol,":[8],"triglyceride":[9],"and":[10,29,53,60,69,119,126,142,147,177,201,237,259,278,311,313],"glucose":[11,227],"lowering":[12],"primarily":[13,31],"through":[14,255],"its":[15],"action":[16],"in":[17,21,27,90,107,129,298],"the":[18,34,54,65,91,116,302],"liver.":[19],"However,":[20],"excess,":[22],"TH":[23,79,87],"causes":[24],"adverse":[25,62],"effects":[26,63],"heart":[28,68,92],"bone":[30],"mediated":[32],"by":[33,220],"THR-alpha":[35],"receptor.":[36],"VIA-3196":[37,81,136,193,211,251,272,289,300],"is":[38,168],"a":[39,72,86,169,229],"novel":[40],"THRbeta":[41],"receptor":[42],"selective":[43],"(17/1":[44],"relative":[45],"to":[46,112,228,235,304,307],"TH)":[47],"thyromimetic":[48],"with":[49,78,109,131,286,309],"high":[50,95],"hepatic":[51,274],"uptake":[52],"possibility":[55],"of":[56,85,172,184,209,263,295],"providing":[57],"avoiding":[61],"on":[64,157],"thyroid":[66],"axis,":[67],"bone.":[70],"In":[71,97,133,180,206],"rodent":[73],"hypothyroid":[74],"model,":[75],"compared":[77],"(T3),":[80],"showed":[82],"no":[83],"upregulation":[84],"regulated":[88],"gene":[89,246],"even":[93],"at":[94,162,186,212],"doses.":[96],"hypercholesterolemic":[98,134],"rabbits,":[99],"VIA-":[100],"3196":[101],"lowered":[102,120,137,226],"non-HDL":[103,138],"cholesterol":[104,139,158,196,254,257,269],"alone":[105,125],"or":[106,159],"synergy":[108],"atorvastatin":[110],"up":[111],"50%":[113,127],"(p<0.001),":[114],"increased":[115],"HDL/LDL":[117],"ratio,":[118],"plasma":[121,195],"triglycerides":[122,144,161,203],"35%":[123],"(p<0.05)":[124,233],"(p<0.001)":[128],"combination":[130],"atorvastatin.":[132],"rats,":[135],"73%,":[140],"(p<0.005)":[141],"liver":[143,160,173,202],"66%":[145],"(p<0.0001),":[146],"did":[148,240],"not":[149,241],"decrease":[150],"TSH,":[151],"whereas":[152],"T3":[153],"had":[154],"little":[155],"effect":[156],"doses":[163,187],"that":[164,250,283],"suppressed":[165],"TSH.":[166],"Steatosis":[167],"major":[170],"cause":[171,242],"insulin":[174,216,222],"resistance":[175],"(IR)":[176],"non-alcoholic":[178],"steatohepatitis.":[179],"preclinical":[181],"mouse":[182,207],"models":[183,208],"IR,":[185,210],"low":[189],"0.3":[191],"mg/kg":[192,214],"reduced":[194],"40%":[197],"(p<5\u00d710":[198],"\u22126":[199],")":[200],"51%":[204],"(p<0.05).":[205],"1":[213],"improved":[215],"sensitivity":[217],"demonstrated":[219],"an":[221],"tolerance":[223],"test":[224],"(p<0.05),":[225],"near":[230],"normal":[231],"level":[232],"similar":[234],"rosiglitazone,":[236,239],"unlike":[238],"weight":[243],"gain.":[244],"Hepatic":[245],"expression":[247],"studies":[248],"suggest":[249],"may":[252],"lower":[253],"increasing":[256,267],"metabolism":[258],"biliary":[260],"excretion":[261],"(upregulation":[262],"Cyp7A1,":[264],"ABCB11),":[265],"perhaps":[266],"reverse":[268],"transport.":[270],"Interestingly,":[271],"downregulated":[273],"inflammatory":[275],"genes":[276],"CRP":[277],"Saa2":[279],"(serum":[280],"amyloid":[281],"a2)":[282],"are":[284],"associated":[285],"cardiovascular":[287,320],"risk.":[288],"demonstrates":[290],"good":[291],"pharmaceutical":[292],"properties":[293],"predictive":[294],"qd":[296],"dosing":[297],"humans.":[299],"potential":[303],"provide":[305],"benefit":[306],"patients":[308],"diabetes":[310],"dislipidemia":[312],"ultimately,":[314],"reduce":[315],"their":[316],"risk":[317],"from":[318],"atherosclerotic":[319],"disease.":[321]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}